Page last updated: 2024-10-22

amitriptyline and Carcinoma, Squamous Cell

amitriptyline has been researched along with Carcinoma, Squamous Cell in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leslie, MD1
Glaser, MG1

Other Studies

1 other study available for amitriptyline and Carcinoma, Squamous Cell

ArticleYear
Impaired salivary gland function after radiotherapy compounded by commonly prescribed medications.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Volume: 5, Issue:5

    Topics: Aged; Amiloride; Amitriptyline; Carcinoma, Squamous Cell; Cisplatin; Drug Combinations; Female; Huma

1993